Getting a weight loss injection starts with a prescription from a licensed healthcare provider, either in person or through a telehealth platform. These medications are not available over the counter. You’ll need to meet specific medical criteria, go through a clinical evaluation, and in most cases, navigate insurance requirements or pay out of pocket. Here’s what that process actually looks like.
Who Qualifies for Weight Loss Injections
To get a prescription, you typically need to meet one of two criteria: a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related health condition. Qualifying conditions include high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or heart disease.
Certain medical histories will rule you out. You cannot take these medications if you or a close family member has a history of medullary thyroid cancer or a condition called multiple endocrine neoplasia type 2 (a rare syndrome involving tumors in hormone-producing glands). A history of pancreatitis or gastroparesis, a condition where the stomach empties too slowly, may also disqualify you. Pregnancy is an absolute exclusion.
What Medications Are Available
The main injectable weight loss medications prescribed today use compounds that mimic a gut hormone called GLP-1, which regulates appetite and blood sugar. The two most widely prescribed options are semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes) and tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes). Both are self-administered once-weekly injections using a small pre-filled pen, similar to an insulin pen. There’s also a daily injection called liraglutide (Saxenda), though it’s less commonly prescribed now that the weekly options exist.
An oral tablet form of semaglutide (Rybelsus) is available but is currently approved only for type 2 diabetes, not weight management.
How to Get a Prescription
You have two main paths: your primary care doctor or a telehealth provider. Either route requires a clinical evaluation.
Your doctor will check your BMI, review your medical history, and assess for the contraindications mentioned above. If you have type 2 diabetes, expect a blood sugar check before starting. Your provider should also monitor your heart rate at regular intervals while you’re on the medication, and they’ll want to watch for any changes in mood, including symptoms of depression or unusual behavioral shifts. If you have kidney issues, your provider will likely track your kidney function as well, especially if you experience significant nausea or vomiting.
Telehealth platforms have become a popular route because they streamline access. Several online services are recognized by the manufacturers for legitimate prescribing and medication sourcing. These platforms typically offer virtual consultations with licensed providers, let you review professional qualifications and patient ratings, and can ship medications directly to you. Many accept insurance. If you go this route, verify that the platform connects you with a licensed prescriber in your state and sources FDA-approved medications, not compounded alternatives.
The Dosing Timeline Takes Months
You won’t start at the full dose. Every GLP-1 medication follows a gradual escalation schedule designed to minimize side effects, particularly nausea. For semaglutide (Wegovy), you begin at 0.25 mg per week, a dose that’s considered below the therapeutic threshold. Over several months, your provider increases the dose in steps, potentially reaching 2.4 mg per week at the maintenance level. Tirzepatide (Zepbound) follows a similar pattern, starting at 2.5 mg weekly and scaling up to between 10 and 15 mg.
This means it can take three to five months before you reach the dose where the medication is most effective. If gastrointestinal side effects are significant at any step, your provider may slow the titration further or keep you at a lower maintenance dose. The process requires patience and regular check-ins.
Insurance Coverage Is Not Guaranteed
Insurance coverage for weight loss injections varies widely and often involves significant hurdles. Many plans require prior authorization, which means your provider submits documentation proving you meet specific clinical criteria before the insurer agrees to pay.
A prior authorization form from one major insurer illustrates how strict these requirements can be. To get approved, you may need to demonstrate that you’ve spent at least six months on a structured diet and exercise program without achieving your weight loss goal. Some insurers also require that you’ve tried and failed on a three-month course of older, generic weight loss pills (like phentermine) before they’ll cover a GLP-1 injection. If those older medications are contraindicated for you due to heart conditions or other issues, that requirement can be waived, but you’ll need documentation.
Initial approval typically lasts 12 months, after which you’ll need to renew. At renewal, your insurer may require proof that the medication is working. For adults, this usually means losing at least 5% of your starting body weight. For adolescents aged 12 to 17, the threshold is 4%. If you haven’t hit that target on the full dose, coverage may be denied.
Without insurance, these medications can cost over $1,000 per month at retail price. Manufacturer savings programs exist but have eligibility restrictions, and they typically don’t apply if you’re on Medicare or Medicaid.
Why to Avoid Compounded Versions
The high cost of brand-name injections has driven many people toward compounded versions, which are custom-mixed by specialty pharmacies. This carries real risks. The FDA has issued direct warnings about compounded semaglutide products, noting that they do not undergo premarket review for safety, quality, or effectiveness.
The problems are concrete. Compounded semaglutide comes in various containers and concentrations that differ from one compounder to the next, and even a single compounder may offer multiple concentrations. Some label doses in “units” rather than milligrams, which creates confusion about how much you’re actually injecting. The FDA has received reports of dosing errors with compounded semaglutide that led to hospitalization, including cases of acute pancreatitis, gallstones, severe dehydration, and fainting.
Some compounders also add extra ingredients like vitamin B-12, L-carnitine, or other supplements to their semaglutide products. The safety of these combinations has never been studied. Others use salt forms of semaglutide (semaglutide sodium or semaglutide acetate) rather than the base form used in FDA-approved products. The FDA has stated it is not aware of any legal basis for compounding with these salt forms. If a provider or online service is offering semaglutide at a steep discount, particularly from a compounding pharmacy, treat that as a red flag rather than a bargain.
What the First Few Weeks Look Like
Once you have your prescription and your first pen arrives, the injection itself is straightforward. You pick a day of the week, inject into your abdomen, thigh, or upper arm, and repeat on the same day each week. The needle is short and thin, similar to what people use for insulin.
The most common early side effects are gastrointestinal: nausea, sometimes vomiting, and changes in appetite that can feel dramatic. These tend to peak when your dose increases and often ease as your body adjusts. Eating smaller meals and avoiding high-fat foods helps. If nausea is severe, your provider may slow the dose escalation or temporarily drop you back to a lower dose.
These medications are prescribed alongside diet and exercise changes, not as a replacement for them. The clinical criteria for both prescribing and insurance renewal assume you’re actively engaged in behavioral modifications throughout treatment. Weight loss typically becomes noticeable within the first two to three months and continues as the dose increases, with the most significant results appearing after six months to a year on a maintenance dose.